Stay updated on ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T14:21:31.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The webpage has added a section with helpful links provided by Pfizer, which includes information on how to obtain contact details for a study center nearby.
    Difference
    0.3%
    Check dated 2025-04-23T12:33:49.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed descriptions of a clinical study involving ARRY-382 and pembrolizumab, while retaining the study's identifier and revision number.
    Difference
    12%
    Check dated 2025-04-16T10:22:11.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T04:56:22.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T22:11:24.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The webpage has removed a notice regarding heavy traffic affecting NLM-NCBI services and a link to obtain contact information for a study center provided by Pfizer.
    Difference
    0.9%
    Check dated 2025-02-24T18:33:56.000Z thumbnail image

Stay in the know with updates to ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.